Crohn's Disease

What is Crohn's Disease?

Crohn's disease is a type of Inflammatory Bowel Disease (IBD) that causes chronic inflammation of the gastrointestinal (GI) tract. It can affect any part of the digestive tract, from the mouth to the anus, but most commonly affects the end of the small intestine (ileum) and the beginning of the colon. The inflammation can extend through multiple layers of the bowel wall, leading to various complications.

Common Symptoms of Crohn's Disease

Causes and Risk Factors

Diagnosis

Treatment Options

Prevention and Management Strategies

Complications of Crohn's Disease


8. References & Research

Historical Background

Crohn's disease is named after Dr. Burrill B. Crohn, who, along with colleagues Leon Ginzburg and Gordon Oppenheimer, published a landmark paper in 1932 describing "regional ileitis" as a distinct clinical entity. Earlier descriptions of granulomatous bowel inflammation were made by Giovanni Battista Morgagni in 1769 and T. Kennedy Dalziel in 1913.

Key Research Papers

  1. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. JAMA. 1932;99(16):1323-1329.
  2. Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. The Lancet. 2017;389(10080):1741-1755.
  3. Baumgart DC, Sandborn WJ. Crohn's disease. The Lancet. 2012;380(9853):1590-1605.
  4. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease (SONIC trial). N Engl J Med. 2010;362(15):1383-1395.
  5. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. The Lancet. 2002;359(9317):1541-1549.
  6. Sandborn WJ, Feagan BG, Rutgeerts P, et al. Vedolizumab as induction and maintenance therapy for Crohn's disease (GEMINI 2). N Engl J Med. 2013;369(8):711-721.
  7. Feagan BG, Sandborn WJ, Gasink C, et al. Ustekinumab as induction and maintenance therapy for Crohn's disease (UNITI). N Engl J Med. 2016;375(20):1946-1960.
  8. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119-124.
  9. Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn's disease in adults. Am J Gastroenterol. 2018;113(4):481-517.
  10. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century. The Lancet. 2017;390(10114):2769-2778.
  11. Gomollon F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease (ECCO). J Crohns Colitis. 2017;11(1):3-25.
  12. de Souza HSP, Fiocchi C, Iliopoulos D. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14(12):739-749.

Back to Table of Contents


Video Thumbnail

Crohn's Disease vs Ulcerative Colitis Nursing | Crohn's vs Colitis Chart Symptoms, Treatment

Video Thumbnail

Crohn's Disease Nursing | Crohns Symptoms, Pathophysiology, Treatment, Diet NCLEX

Video Thumbnail

What to do if you have a Crohn's disease or ulcerative colitis flare | GI Society

Video Thumbnail

Ulcerative Colitis, Crohn's Disease & Diverticulitis - Medical-Surgical (GI) | @LevelUpRN

Video Thumbnail

Crohn’s Disease Signs and Symptoms (& Why They Occur), and Complications & Deficiencies

Video Thumbnail

What Is Crohn's Disease And How Is It Treated?

Video Thumbnail

Inflammatory Bowel Disease (Overview, Crohn's and Ulcerative Colitis)

Video Thumbnail

Inflammatory Bowel Disease (IBD): Symptoms, Treatment, and Prevention | Mass General Brigham

Video Thumbnail

Ulcerative Colitis vs. Crohn's Disease - Know the Difference | Med Surg Help for Nursing School